A researcher, Prof. Madubuike Ezeibe, has called on the Federal Government to carry out a clinical trial of the drug he invented, Aluminum-Magnesium Silicate ( AMS ), for the treatment of HIV/AIDS.
Ezeibe, a professor of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike (MOUAU), made the call in an interview in Umuahia on Monday.
Clinical trial is a study that explores whether a medical strategy, treatment, or device is safe and effective for humans.
It shows which medical approaches that work best for certain illnesses or groups of people.
According to the don, he presented a paper on the potential of the drug as both antiviral and raw material, at a world conference on Ethnopharmacology in Chicago, United States, on May 2, 2016.
He said that more than one year after he invented and presented his findings at different international conferences, no authority anywhere in the world had disputed the research findings.
“I therefore appeal to the federal government to institute an inter-ministerial committee to carry out clinical trial of the drug in six centres across the country without further delay.
“The committee should comprise federal Ministries of Health, Education, Environment as well as Science and Technology, with, at least, 1000 sample patients from each state of the federation.
“Some of the findings of the research include that silicates have molecules that are 0.96 nanometer in size while HIV has molecules as big as 110 nanometer.
“The particles of AMS are positively and negatively charged, while HIV-infected cells are positively charged.